Phreesia, Inc. (PHR)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:52AM EDT. Market open.
| Previous close | 20.46 |
| Open | 20.56 |
| Bid | 20.78 x 800 |
| Ask | 20.84 x 1100 |
| Day's range | 20.57 - 20.88 |
| 52-week range | 12.05 - 34.98 |
| Volume | |
| Avg. volume | 498,962 |
| Market cap | 1.17B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Phreesia Announces Jack Callahan as New Chief Technology Officer
ALL-REMOTE COMPANY/WILMINGTON, Del., March 19, 2024--Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer.
- Business Wire
Phreesia Announces Fourth Quarter Fiscal 2024 Results
WILMINGTON, Del., March 14, 2024--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024.
- Business Wire
Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
WILMINGTON, Del., February 27, 2024--Phreesia announces that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in NQF's 2024-2025 Leadership Consortium.
© 2024 Yahoo. All rights reserved.